XLONIHC
Market cap14mUSD
Dec 24, Last price
12.50GBP
1D
0.00%
1Q
-41.86%
Name
Inspiration Healthcare Group PLC
Chart & Performance
Profile
Inspiration Healthcare Group plc, together with its subsidiaries, supplies medical technology for critical care, operating theatre, and home healthcare applications worldwide. The company provides neonatal intensive care products, such as inspiration air/oxygen blenders; Tecotherm Neo, a servo control device for total body cooling and warming to monitor the infant's temperature for every 2 seconds and making minute changes to the cooling fluid to ensure that the infant's temperature remains stable; LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. It also offers adult intensive care products; AlphaCore5, a patient warming system for the prevention of inadvertent hypothermia; and CosyTherm2, a patient warming system for the management of body temperature in neonates. In addition, the company provides respiratory disposables and thermo-regulating products for babies. Further, it is involved in the distribution of third party products, including infusion therapy products for parenteral feeding and chemotherapy applications; and provision of technology support services and spare parts. Inspiration Healthcare Group plc was incorporated in 1998 and is headquartered in Crawley, the United Kingdom.
IPO date
Dec 14, 2001
Employees
210
Domiciled in
GB
Incorporated in
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | 2018‑01 | 2017‑01 | 2016‑01 | 2015‑01 | |
Income | ||||||||||
Revenues | 37,630 -8.74% | 41,233 0.45% | 41,050 11.01% | |||||||
Cost of revenue | 24,101 | 39,743 | 36,279 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 13,529 | 1,490 | 4,771 | |||||||
NOPBT Margin | 35.95% | 3.61% | 11.62% | |||||||
Operating Taxes | 358 | (196) | (271) | |||||||
Tax Rate | 2.65% | |||||||||
NOPAT | 13,171 | 1,686 | 5,042 | |||||||
Net income | (6,034) -2,318.38% | 272 -93.58% | 4,234 50.41% | |||||||
Dividends | (420) | (419) | (412) | |||||||
Dividend yield | 1.64% | 1.17% | 0.58% | |||||||
Proceeds from repurchase of equity | (244) | |||||||||
BB yield | 0.35% | |||||||||
Debt | ||||||||||
Debt current | 2,351 | 2,901 | 647 | |||||||
Long-term debt | 16,653 | 10,176 | 13,072 | |||||||
Deferred revenue | 8,251 | |||||||||
Other long-term liabilities | (4,000) | (1,925) | ||||||||
Net debt | 18,395 | (6,900) | (9,583) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 2,012 | (3,515) | 3,535 | |||||||
CAPEX | (434) | (8,342) | (3,971) | |||||||
Cash from investing activities | (2,685) | (8,342) | (3,971) | |||||||
Cash from financing activities | (1,191) | 4,880 | (964) | |||||||
FCF | 15,270 | (9,660) | (3,270) | |||||||
Balance | ||||||||||
Cash | 609 | 2,276 | 9,253 | |||||||
Long term investments | 17,701 | 14,049 | ||||||||
Excess cash | 17,915 | 21,249 | ||||||||
Stockholders' equity | 9,783 | 16,632 | 16,651 | |||||||
Invested Capital | 41,798 | 29,737 | 24,089 | |||||||
ROIC | 36.82% | 6.26% | 20.28% | |||||||
ROCE | 32.37% | 3.09% | 11.18% | |||||||
EV | ||||||||||
Common stock shares outstanding | 68,217 | 68,819 | 68,794 | |||||||
Price | 0.38 -27.88% | 0.52 -49.27% | 1.03 18.50% | |||||||
Market cap | 25,581 -28.52% | 35,786 -49.25% | 70,513 46.76% | |||||||
EV | 43,976 | 28,886 | 60,930 | |||||||
EBITDA | 15,966 | 3,775 | 6,677 | |||||||
EV/EBITDA | 2.75 | 7.65 | 9.13 | |||||||
Interest | 810 | 395 | 301 | |||||||
Interest/NOPBT | 5.99% | 26.51% | 6.31% |